Advertisement

This Year in Medicine 2024: Stories that Defined Healthcare

Published on: 

An overview and landing page for future installments from HCPLive's 8th annual This Year in Medicine Series.

As we turn the page on 2024, healthcare systems, professionals, and patients, in many ways, find themselves at a crossroads as they prepare to enter 2025.

2024 was a record year in medicine. With a slew of historic approvals in a multitude of disease states, many specialties find themselves amidst a renaissance of care.

However, even with all this advancement, for many, this year was more of the same—earmarked by struggles to overcome the impact of decades-long barriers to care to provide equitable access and care for underserved communities.

Throughout December, This Year in Medicine, the 8th edition of our annual series reflecting on the groundbreaking stories, persistent challenges, and transformative innovations in healthcare, will feature in-depth articles and multimedia content, spotlighting the most impactful developments within our areas of focus.

As always, this year’s series is a collaboration across the HCPLive Network:

From new therapeutic advances in MASH/MASLD, heart failure, and menopause to the profound early impact of artificial intelligence in neurology, from regulatory milestones like needle-free treatments and home OCT to the evolving understanding of antimicrobial resistance and long COVID, this year’s stories reflect the diversity and dynamism of medicine in 2024.

Stay connected with This Year in Medicine on Facebook, Twitter, and LinkedIn using the hashtag #ThisYearInMedicine, or follow the series on HCPLive’s homepage and daily newsletter. Thank you for joining us in this exploration of healthcare’s continued evolution.

In the future, you will be able to find a list and summaries for each piece of content featured in our This Year in Medicine series. Remember to check back throughout December for new installments and insights!

--------------------

Installments:

Endoscopy in the Age of GLP-1 RAs: 2024 Sees New Risk-Based Perioperative Guidance

To withhold or not to withhold? That was the question for many in 2024 as the community processed how to digest and implement new information on withholding GLP-1 RAs ahead of endoscopic procedures during 2024.

System Integration: How AI Is Weaving Itself into Neurology

Artificial intelligence has quickly found a home in medicine, but what does it mean for neurology specifically? Find out in this article, with perspective across more than half a dozen disease states in neurology.

A Pillared Approach: A Suite of Therapies for a Spectrum of Disease

In recent years, a collection of therapeutic classes and agents have redefined the management of metabolic disease. In 2024, these therapies entered a new realm—heart failure with preserved ejection fraction.

The Long COVID Patient Journey: A Complex and Uncertain Road

More than 4 years removed from the peak of the COVID-19 pandemic in 2020, health systems are now grappling with challenges posed by long-term sequelae of the disease.


Advertisement
Advertisement